Patrick Sartore - ProMetic Life Insider

ProMetic Life Sciences Inc -- Germany Stock  

EUR 0.84  0.03  3.7%

Senior Legal Counsel, Corporate Secretary

Mr. Patrick Sartore is a Chief Legal Officer and Corporationrationrate Secretary of the Company. Mr. Patrick Sartore joined Prometic in 2006 as Senior Legal Counsel Intellectual Property, was nominated Corporationrationrate Secretary of the Corporationrationration in 2007. Mr. Sartore held the position of General Counsel and Corporationrationrate Secretary from May 2013 to May 2015, at which date he was appointed Chief Legal Officer and Corporationrationrate Secretary. Mr. Sartore was previously employed by Univalor Inc. as Legal Counsel and Leger Robic Richard, L.L.P., a firm specializing in Intellectual Property, Corporationrationrate and Commercial Law, as an associate attorney. Mr. Sartore has extensive experience in the areas of intellectual property, technology transfer, licensing and commercialization, private and public financing as well as general corporate and commercial law, namely in the biopharmaceutical field. Mr. Sartore graduated from the University of Montreal with a Bachelor of Law in 1999 and was called to the Bar of Qubec in 2001
  Executive Since 2015      
Sartore also holds a BS, with Distinction, from Concordia University.

Management Efficiency

The company has return on total asset (ROA) of (29.94) % which means that it has lost $29.94 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (84.14) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 52.89 M in total debt with debt to equity ratio (D/E) of 52.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProMetic Life Sciences Inc has Current Ratio of 1.56 which is within standard range for the sector.

Similar Executives

Found 14 records

EXECUTIVE Since

Xiquan WangIndustrial and Commercial Bank
2015
Hao HuIndustrial and Commercial Bank
2016
Huiman YiIndustrial and Commercial Bank
2016
Hongli ZhangIndustrial and Commercial Bank
2015
Jingdong WangIndustrial and Commercial Bank
2016
Guoxiong WeiIndustrial and Commercial Bank
2006
Walter MullerBank of America Corporation
N/A
Xueqing GuanIndustrial and Commercial Bank
2016
Jiong TanIndustrial and Commercial Bank
2017
Xiaoxuan LinIndustrial and Commercial Bank
2010
Wanchun ZhengIndustrial and Commercial Bank
2013
Shu GuIndustrial and Commercial Bank
2016
Yunze LiIndustrial and Commercial Bank
2016
Bairong WangIndustrial and Commercial Bank
2016

Entity Summary

ProMetic Life Sciences Inc (PJ2) is traded on Frankfurt Stock Exchange in Germany. and employs 19 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ProMetic Life Sciences Inc to your portfolio

Top Management

ProMetic Life Sciences Leadership Team
Nancy Orr, Director
Louise Menard, Director
Simon Best, Chairman, MBA
Steve Burton, CEO, Ph.D
Andrew Bishop, Director, MBA
Patrick Sartore, Executive
DwunHou Chen, President, Ph.D
Bruce Wendel, Director
Gregory Weaver, CFO, CPA
Pierre Laurin, CEO
John Moran, Director, Ph.D
Stefan Clulow, Director
Kenneth Galbraith, Director
Bruce Pritchard, CFO
Benjamin Wygodny, Director
Raymond Hakim, Director
Charles Kenworthy, Director
Paul Mesburis, Director, MBA
Frederic Dumais, Director

Stock Performance

ProMetic Life Performance Indicators
Return On Equity(84.14) %
Return On Asset(29.94) %
Operating Margin(751.25) %
Current Valuation657.37 M
Price to Earning(7.07) times
Price to Book7.02 times
Price to Sales51.8 times
Revenue12.79 M
EBITDA(93.26 M)
Net Income(93.02 M)